Medicine
Levetiracetam 500 mg/5 mL injection
Levetiracetam 500 mg/5 mL injection is a generic prescription medicine for intravenous use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Key facts
- Active ingredient (INN)
- Levetiracetam
- Brand
- Sold under the generic name
- Strength
- 500 mg/5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 5 mL, 25 vials of 5 mL, 5 vials of 5 mL and 26 more
- Manufacturers
- Micro LabsIndiaNovadoz PharmaceuticalsIndiaEugiaIndiaHikma PharmaceuticalsMethod PharmaceuticalsArmas PharmaceuticalsBaxter HealthcareBryant Ranch PrepackFresenius KabiHospira
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AX14 Levetiracetam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 August 2011
- Identifiers
- RxCUI 647121DailyMed set ID 484e8d8f-be40-46f8-a509-d1bbdbbd2981, cc41696c-9cf0-4410-bacc-09132ee805ce, 7be45c40-8d75-4c40-97a4-95067129bc2a +16NDC 72205-120, 63323-400, 72485-106 +15Application ANDA215980, ANDA090876, ANDA211954 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 55150-177-05 | EugiaIndia | 1 February 2016 |
| 25 vial in 1 carton / 5 mL in 1 vial | 42571-331-38 | Micro LabsIndia | 3 August 2026 |
| 10 vial in 1 carton / 5 mL in 1 vial | 42571-331-92 | Micro LabsIndia | 4 October 2019 |
| 10 vial in 1 carton / 5 mL in 1 vial | 72205-120-07 | Novadoz PharmaceuticalsIndia | 9 February 2023 |
| 25 vial in 1 carton / 5 mL in 1 vial | 72205-120-25 | Novadoz PharmaceuticalsIndia | 9 February 2023 |
| 10 vial, single-use in 1 tray / 5 mL in 1 vial, single-use | 63323-400-05 | Fresenius Kabi | 13 August 2015 |
| 10 vial, single-use in 1 tray / 5 mL in 1 vial, single-use | 63323-400-44 | Fresenius Kabi | 13 August 2015 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0143-9574-10 | Hikma Pharmaceuticals | 1 June 2015 |
| 25 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0143-9574-25 | Hikma Pharmaceuticals | 1 June 2015 |
| 10 vial, glass in 1 box / 5 mL in 1 vial, glass | 0143-9673-10 | Hikma Pharmaceuticals | 13 October 2011 |
| 25 vial, glass in 1 carton / 5 mL in 1 vial, glass | 0143-9673-25 | Hikma Pharmaceuticals | 13 October 2011 |
| 25 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0409-1886-02 | Hospira | 2 November 2012 |
| 25 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0409-2011-25 | Hospira | 1 November 2021 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 72485-106-10 | Armas Pharmaceuticals | 14 January 2021 |
| 25 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 72485-106-25 | Armas Pharmaceuticals | 16 March 2023 |
| 10 vial in 1 carton / 5 mL in 1 vial | 85957-037-02 | Aryeh Pharma | 10 April 2026 |
| 5 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 36000-265-05 | Baxter Healthcare | 6 August 2026 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 36000-265-10 | Baxter Healthcare | 6 August 2026 |
| 1 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 58657-860-01 | Method Pharmaceuticals | 15 December 2025 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 58657-860-10 | Method Pharmaceuticals | 15 December 2025 |
| 25 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 58657-860-25 | Method Pharmaceuticals | 15 December 2025 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 67457-790-05 | Mylan Institutional | 24 July 2017 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 43547-454-10 | Solco Healthcare | 11 April 2022 |
| 5 mL in 1 vial | 39822-4000-1 | XGen Pharmaceuticals DJB | 5 August 2011 |
| 10 vial in 1 carton / 5 mL in 1 vial | 72162-2638-2 | Bryant Ranch Prepack | 6 May 2026 |
| 25 vial in 1 carton / 5 mL in 1 vial | 72162-2638-4 | Bryant Ranch Prepack | 6 May 2026 |
| 25 vial in 1 carton / 5 mL in 1 vial | 72572-360-25 | Civica | 1 December 2022 |
| 10 vial, single-use in 1 carton / 5 mL in 1 vial, single-use | 68094-313-10 | Precision Dose | 10 October 2024 |
| 25 vial, single-use in 1 carton / 5 mL in 1 vial, single-use | 68094-313-25 | Precision Dose | 10 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Levetiracetam 500 mg/5 mL injection.
Other strengths and forms of Levetiracetam
Clinical summary
Levetiracetam is a prescription medicine indicated for the treatment of partial-onset seizures in patients 1 month of age and older, among other approved uses. MedsAcross supplies Levetiracetam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LevetiracetamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Keppra prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Keppra: European public assessment report (EPAR) · European Medicines Agency
- Levetiracetam Accord: European public assessment report (EPAR) · European Medicines Agency
Need Levetiracetam 500 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.